ATE398141T1 - Gegen den marburg i polymorphismus der faktor vii aktivierenden protease (fsap) gerichtete antikörper, ihre herstellung und verwendung - Google Patents

Gegen den marburg i polymorphismus der faktor vii aktivierenden protease (fsap) gerichtete antikörper, ihre herstellung und verwendung

Info

Publication number
ATE398141T1
ATE398141T1 AT05018249T AT05018249T ATE398141T1 AT E398141 T1 ATE398141 T1 AT E398141T1 AT 05018249 T AT05018249 T AT 05018249T AT 05018249 T AT05018249 T AT 05018249T AT E398141 T1 ATE398141 T1 AT E398141T1
Authority
AT
Austria
Prior art keywords
fsap
antibodies
variant
amino acids
marburg
Prior art date
Application number
AT05018249T
Other languages
German (de)
English (en)
Inventor
Harald Althaus
Herbert Schwarz
Bodo Fischer
Thomas Wissel
Original Assignee
Dade Behring Marburg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg Gmbh filed Critical Dade Behring Marburg Gmbh
Application granted granted Critical
Publication of ATE398141T1 publication Critical patent/ATE398141T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05018249T 2004-08-24 2005-08-23 Gegen den marburg i polymorphismus der faktor vii aktivierenden protease (fsap) gerichtete antikörper, ihre herstellung und verwendung ATE398141T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004041104 2004-08-24
DE102005026163A DE102005026163A1 (de) 2004-08-24 2005-06-06 Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ATE398141T1 true ATE398141T1 (de) 2008-07-15

Family

ID=35448125

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05018249T ATE398141T1 (de) 2004-08-24 2005-08-23 Gegen den marburg i polymorphismus der faktor vii aktivierenden protease (fsap) gerichtete antikörper, ihre herstellung und verwendung

Country Status (8)

Country Link
US (2) US7622558B2 (enExample)
EP (1) EP1630175B1 (enExample)
JP (1) JP4944410B2 (enExample)
AT (1) ATE398141T1 (enExample)
AU (1) AU2005203794A1 (enExample)
CA (1) CA2516876A1 (enExample)
DE (2) DE102005026163A1 (enExample)
ES (1) ES2308353T3 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060212176A1 (en) * 2005-02-18 2006-09-21 Corum James F Use of electrical power multiplication for power smoothing in power distribution
DE502006005169D1 (de) * 2005-12-22 2009-12-03 Siemens Healthcare Diagnostics Diagnostisches Verfahren zur Erkennung von Trägern der Marburg l-Variante der Faktor VII-aktivierenden Protease (FSAP) anhand differenzieller Modulation der FSAP-Aktivität
RU2395575C1 (ru) * 2008-12-15 2010-07-27 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора) ШТАММ ГИБРИДНЫХ КЛЕТОК ЖИВОТНОГО Mus musculus L. - ПРОДУЦЕНТ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ ДЛЯ ВЫЯВЛЕНИЯ БЕЛКА VP40 ВИРУСА МАРБУРГ (ШТАММ Рорр) (ВАРИАНТЫ), МОНОКЛОНАЛЬНОЕ АНТИТЕЛО, ПРОДУЦИРУЕМОЕ ШТАММОМ (ВАРИАНТЫ), НАБОР ДЛЯ ИММУНОФЕРМЕНТНОЙ ТЕСТ-СИСТЕМЫ ФОРМАТА "СЭНДВИЧ" ДЛЯ ВЫЯВЛЕНИЯ МАТРИКСНОГО БЕЛКА VP40 ВИРУСА МАРБУРГ (ШТАММ Рорр)
RU2393220C1 (ru) * 2008-12-15 2010-06-27 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора) Штамм гибридных клеток животного mus musculus l. 3f9 - продуцент моноклональных антител, пригодных для использования в иммуноферментной системе формата "сэндвич" для выявления белка vp35 вируса марбург, и моноклональные антитела 3f9, продуцируемые указанным штаммом гибридных клеток
GB0916576D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
EP2386652A1 (de) 2010-05-12 2011-11-16 Siemens Healthcare Diagnostics Products GmbH Homogenes Verfahren zur Bestimmung der Plasminogenaktivator-aktivierenden Aktivität der FSAP
US9075055B2 (en) 2013-03-15 2015-07-07 Hycor Biomedical, Inc. Device and associated methods for performing luminescence and fluorescence measurements of a sample
JP6485854B2 (ja) * 2014-09-24 2019-03-20 国立研究開発法人国立循環器病研究センター 抗変異型プロテインs抗体、該抗体を含む診断用組成物、変異型ヒトプロテインsの検出方法および該抗体を含むキット

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
DE3145082A1 (de) * 1981-11-13 1983-05-19 Behringwerke Ag, 3550 Marburg "ein latex, biologisch aktive latexkonjugate und verfahren zu ihrer herstellung"
DE3545595A1 (de) * 1985-12-21 1987-06-25 Behringwerke Ag Dispersionspolymere, verfahren zu ihrer herstellung und ihre verwendung
US5183766A (en) * 1986-04-18 1993-02-02 Behringwerke Aktiengesellschaft Dispersion polymers, processes for their preparation and their use
DE3613111A1 (de) 1986-04-18 1987-10-22 Behringwerke Ag Dispersionspolymere, verfahren zu ihrer herstellung und ihre verwendung
US5512659A (en) 1989-08-04 1996-04-30 Syntex (U.S.A.) Inc. Compositions useful in heterogeneous immunoassays
AU657134B2 (en) 1991-05-22 1995-03-02 Dade Behring Marburg Gmbh Assay methods utilizing induced luminescence
US5340716A (en) * 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
CA2140661A1 (en) * 1992-07-20 1994-02-03 Sharat Singh Novel chemiluminescent compounds and methods of use
JP3498960B2 (ja) 1993-09-03 2004-02-23 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 蛍光酸素チャンネリングイムノアッセイ
FR2717499B1 (fr) 1994-03-17 1996-05-24 Ulp Fragments d'anticorps recombinants synthétisés et biotinylés dans E. coli, leur utilisation en immunodosages et en purification par immunoaffinité.
DE19903693A1 (de) 1998-04-24 1999-10-28 Centeon Pharma Gmbh Protease zur Aktivierung des Gerinnungsfaktors VII
DE10023923A1 (de) 1999-06-10 2000-12-14 Aventis Behring Gmbh Verfahren zur Bestimmung der Aktivität der Faktor VII-aktivierenden Protease aus Proteinlösungen
US7153679B2 (en) * 2000-07-26 2006-12-26 Aventis Behring Gmbh Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis
EP1650305B1 (de) * 2000-07-26 2009-08-12 CSL Behring GmbH Mutanten der den Faktor VII aktivierenden Protease und Nachweisverfahren mit spezifischen Antikörpern
GB0108491D0 (en) * 2001-04-04 2001-05-23 Gendaq Ltd Engineering zinc fingers

Also Published As

Publication number Publication date
JP4944410B2 (ja) 2012-05-30
US7951910B2 (en) 2011-05-31
US7622558B2 (en) 2009-11-24
US20100145009A1 (en) 2010-06-10
US20060045879A1 (en) 2006-03-02
DE102005026163A1 (de) 2006-03-02
EP1630175B1 (de) 2008-06-11
EP1630175A1 (de) 2006-03-01
AU2005203794A1 (en) 2006-03-16
CA2516876A1 (en) 2006-02-24
JP2006083166A (ja) 2006-03-30
DE502005004379D1 (de) 2008-07-24
ES2308353T3 (es) 2008-12-01

Similar Documents

Publication Publication Date Title
Jilek et al. Biosynthesis of a D-amino acid in peptide linkage by an enzyme from frog skin secretions
ATE440868T1 (de) Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen
Shimizu et al. Experimental determination of proline hydroxylation and hydroxyproline arabinogalactosylation motifs in secretory proteins
ATE446317T1 (de) Spezifische bindungsproteine und ihre verwendung
JP4372340B2 (ja) アポトーシス関連化合物およびその使用
DE50015156D1 (de) Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung
US20100221255A1 (en) Apelin peptides and methods of use
WO2005087811A3 (en) Estrogen receptors and methods of use
JP2005502319A5 (enExample)
ATE398141T1 (de) Gegen den marburg i polymorphismus der faktor vii aktivierenden protease (fsap) gerichtete antikörper, ihre herstellung und verwendung
Pomes et al. IgE reactivity of tandem repeats derived from cockroach allergen, Bla g 1
Wasniowska et al. Structural characterization of the epitope recognized by the new anti‐Fy6 monoclonal antibody NaM185‐2C3
CA2287545A1 (en) Ma family polypeptides and anti-ma antibodies
JP3829226B2 (ja) ビメンチンの切断産物に対する抗体
JP2012082210A (ja) Adamts13活性検定用抗体及び活性検定方法
WO2008142664A3 (en) Exposed thymidine kinase 1 peptides, ligands and methods employing the same
AU601963B2 (en) Modified beta-2-microglobulin
HUP0101987A2 (hu) Antibiotikus hatású proteinek és peptidek indukciója LAIT/sCD14-proteinnel
KR20230174589A (ko) 비타민 관련 바이오 복합체에 특이적으로 결합하는 펩타이드 및 이의 용도
CA2367468A1 (en) Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis
DE502004008729D1 (de) Gegen das Prothrombin-Fragment F1+2 gerichtete Antikörper, ihre Herstellung und Verwendung
CN101074263B (zh) 一种重组抗proteinA单克隆抗体及其制备方法和用途
WO2002018562A1 (en) Airway-specific trypsin-like enzymes and method of using the same
AU768549B2 (en) Monoclonal antibody against canine trypsin
JP4059404B2 (ja) 甲状腺機能を刺激する活性を持つ抗体